CBA-1205
N/A
Report date: 2022/12/27 14:13:38
Base Information
Drug NameCBA-1205
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChiome Bioscience Inc
China Registration ClassN/A
Develop Information
Active CompaniesChiome Bioscience Inc
Inactive CompaniesN/A
Active Indications +[6]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A